Dr. John Spencer Ellis Reveals Why Men Over 50 Look Older and Which Common Advice is Myth
Nov 7, 2026
Las Vegas, Nevada Nov 7, 2026 (Issuewire.com) - Dr. John Spencer Ellis, a health, longevity and performance coach with more than three decades in the field, has released a 27-page evidence review examining how declining appearance after 50 affects men's confidence and working life, and how much of it is actually within a man's control. The review draws on 48 primary sources and is available free at https://johnspencerellis.com/why-you-look-older-after-50-and-what-the-research-says-actually-matters/.
The problem men describe, and rarely say out loud
Men seldom open a conversation by saying they are unhappy with their face. What they report instead is a change in how a room responds to them. A younger colleague being listened to in the way they used to be. Working as hard as ever and getting less back. Catching a reflection in a shop window and not recognizing the man.
The appearance part surfaces later and sideways -- a photograph someone else posted, a remark from an adult child, the realization that a suit that used to work no longer does.
"Men will discuss almost anything before they discuss this," said Dr. Ellis, who is 57. "And when they finally do, the advice waiting for them is either that it's vanity and they should get over it, or that it's a crisis and here's what to buy. Both responses are ways of not engaging with it."
What the research actually found
The review's central finding reframes the problem. In a controlled experiment with 383 adults and 264 professional recruiters, candidates were presented with the age on their résumé and the apparent age of their face varied independently.
Stating that a candidate was 50 rather than 30 had no effect on hireability whatsoever -- a result of p=0.965. Digitally aging the candidate's face did reduce hireability, but not through attractiveness, which had been matched across the photographs. The entire effect ran through assumed physical fitness.
Critically, when raters were simply told the candidate was physically fit, the penalty for looking older disappeared.
A second finding cuts against the premise of most men's anti-aging marketing. Pooled across 331 longitudinal samples and more than 160,000 people, men's self-esteem does not collapse in midlife -- it peaks between 60 and 70.
"That's the fact I most want men to hear," said Dr. Ellis. "If your confidence is falling at 55, you are moving against the trend. That makes it a problem with a cause, not a stage of life you have to accept."
How much is genetics, and how much is habit
In 387 Danish twin pairs -- 176 of them male -- heritability of perceived facial age was 58%, with a confidence interval of 48 to 65%. Roughly 40% is not explained by genes.
In 318 Dutch men aged 45 to 75, a short list of modifiable factors accounted for 9.3 years of higher perceived facial age: smoking, sun exposure, sunbed use, skin that reddens in sun, and two dental factors.
The review's most hopeful finding concerns reversal. In 1,602 men, current smokers carried 15.5% more facial wrinkling, while former smokers showed no residual excess at all.
Why men need guidance to act on this
The review argues that the information is not the barrier. Most of what works is free, simple and widely known -- and almost never sustained.
Three reasons recur. Men consistently misallocate their effort: eye-tracking research shows the jawline and forehead are the least-fixated of nine facial regions, yet they absorb most of the attention and spending. Men cannot audit themselves reliably, because self-rated attractiveness diverges measurably from how others actually rate them. And the sequence matters enormously -- procedures perform better, and are needed less, on a man who has already addressed the free items, yet most men arrive wanting the procedure first.
"There's a specific failure mode I see constantly," said Dr. Ellis. "A man spends two thousand dollars on his hairline because he read that balding ages you eight years. That figure came from a hair clinic's own survey. The two best studies ever done -- 739 male twins and separately 1,602 men -- found baldness statistically non-significant for perceived age. Meanwhile the things that genuinely move the number are sitting there costing nothing."
About the report
The review covers the measurable changes behind facial aging, heredity versus habit, what observers actually notice when judging a man's age, what the twin data reveal about perceived age and survival, and which treatments survive scrutiny once trial funding is accounted for. Sources, sample sizes, confidence intervals and industry funding are disclosed throughout, and several findings contradict services within Dr. Ellis' own field.
The report is free and requires no purchase.
Read the full article and request the special report:
Source :Dr. John Spencer Ellis
This article was originally published by IssueWire. Read the original article here.
eGovPH superapp to include SSS services, digital ID
MANILA, Philippines – The Social Security System (SSS) and the Department of Information and Communications Technology (DICT) signed a data-sharing agreement to bring the MySSS card and select member services to the eGovPH superapp. Members will also be able to view their contribution history, their total number of contributions, and employer information on integration. “Our
China’s AI chipmakers report first profits, but will the trend continue?
China’s pure-play artificial intelligence chipmakers crossed an important milestone in the third quarter as several firms swung into profit, but severe supply chain hurdles and soaring memory costs cloud their long-term growth prospects. Domestic graphics processing unit (GPU) developers including Moore Threads, MetaX and Iluvatar CoreX are racing to fill the market void left by Nvidia, whose high-end processors face strict US export controls. These home-grown firms are competing fiercely to win...
Nvidia finalizes payment of $1 bil., acquires over 4% stake in Naver
Nvidia Corp. has finalized its payment of $1 billion of investments to Naver Corp. on Friday and acquired 4.13 percent of the portal operator's shares through a third-party rights offering. The South Korean company said it has issued over 6.5 million shares through a private placement involving the U.S. chipmaker, after receiving 1.3 trillion won ($1 billion) in proceeds, according to its regulatory filing. Nvidia's stake acquisition of Naver is set to speed up their joint artificial intelligence (AI) factory venture announced in June. Naver plans to construct graphics processing unit (GPU)-based infrastructure, starting with its Gak Sejong data center in the central city, to expand its GPU-as-a-service businesses.
Temu says 91% of surveyed Korean sellers report business gains
Chinese e-commerce platform Temu said Friday that a survey it conducted found that 91 percent of Korean sellers reported improvements in their businesses after joining the online marketplace, including increased sales and access to new customers. The company-run survey of more than 100 sellers, conducted in August, found that 58 percent reported higher sales volumes, while 47 percent said they had reached new customer groups. Temu entered Korea in July 2023 and fully introduced its Local Seller Program in May last year, allowing domestic merchants to sell to consumers nationwide. About 66 percent of the survey respondents had been selling on the platform for six months or less. Businesses with fewer than 50 employees accounted for 85 percent of the respondents, while 94 percent had already sold through other online channels before joining Temu. Meanwhile, 82 percent viewed Temu as a sales channel that complements their existing sales routes or as a major driver of sales growth. Another 39 percent said they had expanded their operations after joining Temu or planned to do so within 12 mon
Samsung Biologics labor dispute drags on as union stages another strike
Samsung Biologics' unionized workers staged another strike Friday, as wage and collective bargaining negotiations between labor and management have dragged on for more than six months. With global rivals moving quickly to expand their contract drug manufacturing capability, concerns are growing that the prolonged labor dispute could undermine Samsung Biologics' reputation as a reliable supplier capable of delivering the promised volumes of drugs on time. The Samsung Biologics labor union said it began its partial strike on Friday, without holding a separate rally. The strike is scheduled to continue for about three weeks, through Nov. 27. About 400 workers, or 10 percent of the union's roughly 4,000 members, are participating in the strike. They work in departments including quality control testing, quality assurance, logistics and production. Samsung Biologics’ labor and management declared a breakdown in their 2026 wage and collective bargaining negotiations in March, prompting the union to stage a partial strike in April, the first since the company was established in 2011. The union
Lotte Chemical remains in red in Q3
Lotte Chemical Corp. on Friday reported its third-quarter net loss of 289.8 billion won ($213.6 million), remaining in the red compared with a year ago. The company, which makes advanced chemical products and battery materials, said in a regulatory filing that it continued to post an operating loss of 281.4 billion won for the July-September period, compared with a loss of 132.6 billion won a year earlier. Sales rose 12.7 percent to 5.39 trillion won.
Hanwha Engine Q3 net profit down 61.7% to $8.6 mil.
Hanwha Engine on Friday reported its third-quarter net income of 11.6 billion won ($8.6 million), down 61.7 percent from a year earlier. The company, which is part of Korea's largest weapons producer Hanwha Group, said in a regulatory filing that its operating profit for the July-September period stood at 40.9 billion won, up 53.7 percent from a year ago. Sales also rose 39.1 percent to 413.6 billion won. The earnings failed to meet market expectations. The average estimate of net profit by analysts stood at 41.6 billion won, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.
4 decades on, Maestro charts new course in Italian elegance
Introduced in 1986, LF's premium menswear brand Maestro is one of Korea's longest-running menswear labels, having spent four decades adapting its styles and sizing to better suit Korean men's physiques. Marking its 40th anniversary this year, LF said the brand will be more faithful to “Italian elegance” and seek broader global markets beyond Vietnam. LF announced last month that it will further strengthen Albero, Maestro's high-end line featuring Italian-made products, by expanding partnerships with leading Italian textile manufacturers, including Zegna, Loro Piana, Colombo and Piacenza. The company will also expand its made-to-measure (MTM) tailoring services, which account for 30 percent of the brand's sales, by dividing them into three categories: Su Misura, Alta Sartoria and Sartoria Italia. To cater to growing demand from couples preparing for their weddings and consumers in their 20s and 30s who increasingly reserve suits for special occasions, the brand will also expand its formalwear lineup. The Rome Suit, launched in September to celebrate the brand's 40th anniversary, is de
Hankook Tire & Technology Q3 net income down 59.5% to $116.2 mil.
Hankook Tire & Technology on Friday reported its third-quarter net income of 157.9 billion won ($116.2 million), down a sharp 59.5 percent from a year earlier. The firm, one of the largest tire makers in the world, said in a regulatory filing that it posted 598.8 billion won in operating profit for the quarter, compared with 586 billion won a year ago. Revenue rose 1 percent to 5.46 trillion won. The earnings fell behind market expectations. The average estimate of net profit by analysts stood at 298.1 billion won, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.
Kia to invest $2.2 bil. in Gwangju to build PBV mobility ecosystem by 2029
Kia Corp. said Friday it will invest 3 trillion won ($2.2 billion) through 2029 in the southwestern city of Gwangju to establish an ecosystem for purpose-built vehicles (PBVs). The Korean automaker signed a memorandum of understanding with Jeonnam-Gwangju Special Metropolitan City, Chonnam National University, and the Gwangju Institute of Science and Technology (GIST) at its AutoLand plant in Gwangju, about 270 kilometers south of Seoul. Under the agreement, the partners will cooperate in developing PBVs for demand-responsive transport services and testing autonomous PBV shuttles in the city. They will also demonstrate remote driving technology using the PV5 wheelchair-accessible vehicle and test Kia's Easy Swap technology, which allows vehicles to switch between passenger and cargo configurations. Kia said it expects the partnership to strengthen the region's PBV industry and create new growth opportunities by accelerating the development and adoption of advanced mobility services.
Nongshim takes Shin Ramyun food truck to northeastern India
Korean food company Nongshim is running a Shin Ramyun food truck in northeastern India to build its brand in a market of 1.4 billion people, the company said Friday. The truck started its tour Oct. 30 and will continue until Nov. 22, making 20 stops in four cities: Guwahati in Assam, Shillong in Meghalaya, Aizawl in Mizoram and Agartala in Tripura. The stops include university campuses and major residential and shopping areas. Shin Ramyun is Nongshim’s flagship spicy instant noodle brand. “Ramyun” is the Korean word for instant noodles. Nongshim said Shin Ramyun suits Indian tastes because the monsoon climate has made warm soups and noodle dishes popular there. The company described the northeast, where the truck is touring, as a key region with a clear taste for spicy food, a strong noodle culture and a warm reception for Korean pop culture. The tour comes as Nongshim expands its distribution network in the region. At the truck, visitors can try the original Shin Ramyun and Shin Ramyun Toomba, a creamy, spicy variant that takes its cue from cream pasta. The noodles are cooked on-s
SK Biopharmaceuticals builds massive AI dataset to speed up drug discovery
SK Biopharmaceuticals, a Korean firm focused on developing original prescription drugs, has built a massive artificial intelligence (AI) dataset of more than 7 million chemical entries to streamline candidate screening for new therapies. The project is part of the Ministry of Science and ICT’s program to develop AI foundation models for specific fields. A foundation model is a large AI model trained on vast amounts of data that can be adapted for many tasks. SK Biopharmaceuticals belongs to a medical and health care consortium led by medical AI firm Lunit, along with Trillion Labs, Kakao Healthcare and other companies, universities and hospitals. The consortium built a base model specialized in medical science. It then developed versions focused on three areas: drug development, covering chemical compounds and proteins; omics, the large-scale study of genes and other biological molecules; and clinical research. SK Biopharmaceuticals put together the drug discovery dataset based on what researchers actually need in the lab. The data covers 66 drug development tasks, including predictin
Tesla winding down Cybertruck production
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.